Live Breaking News & Updates on அங்கீகாரம் க்கு நீண்டது நடிப்பு

Stay updated with breaking news from அங்கீகாரம் க்கு நீண்டது நடிப்பு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Janssen Pharmaceuticals


Depomed Inc (NASDAQ: DEPO) announced Thursday that it will acquire the U.S. rights to the NUCYNTA franchise from Johnson & Johnson (NYSE: JNJ) subsidiary Janssen Pharmaceuticals, Inc. for $1.05 billion.
According to the company’s press release, “The NUCYNTA franchise. Read More.
Don t Miss Any Updates!
News Directly in Your Inbox
Subscribe to: ....

United Kingdom , Christophers James , Edward Tenthoff , Elemer Piros , Janssen Pharmaceuticalsfriday , Janssen Pharmaceuticals Inc , Arrowhead Pharmaceuticals Inc , Depomed Inc , Akebia Therapeutics Inc , Achillion Pharmaceuticals , Hours Center , Johnson Research And License Agreementfriday , Cantor Fitzgerald , European Union , Janssen Pharmaceuticals , Achillion Pharmaceuticals James , Authorization For Long Acting , Viiv Healthcare , What Happened , React To Arrowhead , Janssen Collaboration , Happened Arrowhead , Following Up Akebia , Research And License Agreementfriday , Analyst Color , Starts Achillion ,

HIV | Benzinga


The Washington Post, citing a Centers for Disease Control and Prevention study, reported the number of annual HIV diagnoses has dropped by 19 percent between 2005 and 2014.
Men who have sex with other men accounted for around 67 percent of all HIV diagnoses in 2014.
HIV cases among women fell by. Read More. ....

United States , United Kingdom , Pharma Stockthursday , Raymond Jame Steven Seedhouse , Yi Chen , David Risinger , Canaccord Genuity , Raymond James , Andrew Baum , Raghuram Selvaraju , Ram Mukunda , Ram Mukundawednesday , Michael Yee , Geoff Meacham , Morgan Stanley , Inovio Pharmaceuticals Inc , India Globalization Capital Inc , Gilead Sciences Inc , Vertex Pharmaceuticals Incorporated , Gates Foundation Deal Opens Things , Washington Post , European Union , Congressional Budget Office , Orasure Technologies Inc , Centers For Disease , Gilead Sciences ,